Atlas Trials

Severe COVID-19

15 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Severe COVID-19

RecordFirmDate
Reparixin add-on Therapy to Standard Care to Limit Progression in Pts With COVID19 & Other Community Acquired Pneumonia (NCT05254990)Dompé Farmaceutici S.p.A2022-04-27
Impact of Post-ARDS Covid-19 Sedation on Persistent Neuroinflammation (NCT05233605)Assistance Publique - Hôpitaux de Paris2022-03-21
COVID-19 and VA-LRTI: Second Versus First Wave of the Pandemic (NCT05256511)University Hospital, Lille2021-11-15
Generation of SARS-CoV-2-specific T Lymphocytes From Recovered Donors and Administration to High-risk COVID-19 Patients (NCT05447013)George Papanicolaou Hospital2021-06-02
Therapeutic Plasma Exchange as an Adjunctive Strategy to Treat Coagulopathy and Inflammation in Severe Covid-19 (NCT04613986)University of Zurich2021-06-01
Corticosteroids in Severe COVID-19 (ASAP-ESICM/ESAIC Study) (NCT04866082)Brno University Hospital2021-05-30
Efficacy and Safety of DWJ1248 With Remdesivir in Severe COVID-19 Patients (NCT04713176)Daewoong Pharmaceutical Co. LTD.2021-02-02
A Study to Evaluate the Efficacy and Safety of VB-201 in Patients With COVID-19 (NCT04733833)Vascular Biogenics Ltd. operating as VBL Therapeutics2021-01-26
Assessment of Efficacy and Safety of Therapy With COVID-19 Convalescent Plasma in Subjects With Severe COVID-19 (IPCO) (NCT04712344)University of Erlangen-Nürnberg Medical School2021-01-18
Oral Probiotics and Secondary Bacterial Pneumonia in Severe COVID-19 (NCT05175833)Universidade de Passo Fundo2020-09-11
Comparative Analysis of Clinical Parameters and Radiographic Changes of Severe COVID-19 (NCT04918901)Second Affiliated Hospital, Zhejiang University, School of Medicine2020-05-01
Safety and Efficacy of Medications COVID-19 (NCT05596617)Hospital San Carlos, Madrid2020-04-22

Track Severe COVID-19 automatically

Every clearance here is in the API, with alerts when new ones post.